Skape Bio Unlocks Generalizable GPCR Drugs Using AI Protein Design - Genetic Engineering and Biotechnology News
9/10Skape Bio utilized advanced AI protein design techniques to develop generalizable GPCR drugs, marking a significant breakthrough in biotech and AI collaboration that could accelerate drug discovery.
